The Inner Circle acknowledges, James W. Edlund, MD as a Pinnacle Lifetime Member

The Inner Circle acknowledges Ilene Fennoy, MD, MPH, as a Pinnacle Professional Member Inner Circle of Excellence

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered "virtual...

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -...

Federal, Provincial and Territorial Ministers Gather to Fast-Track Infrastructure Across Canada

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Wildermuth Fund Mutual Fund Investors to Secure Counsel Before Important Deadline in Securities...

Hagens Berman Sobol Shapiro LLP and Lowey Dannenberg, P.C. Announce Certification of a Class of Third Party Payors Who Purchased or Paid for...

Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of...

Trulieve Announces US$100 Million Private Placement of 10.5% Senior Secured Notes

AI UltraProd Announces U.S. Market Entry with Strategic Focus on High-Growth ADU Sector

JHX IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors to Secure Counsel Before...

Ares Management Set to Join S&P 500; Sezzle and Vital Farms to Join S&P SmallCap 600

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages...

Paramount Declares Quarterly Cash Dividend

Borr Drilling Limited Announces Public Offering of Common Shares

UPDATED: TDECU Adds Two New Members to Board of Directors

FISERV CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Fiserv, Inc. Investors to Contact the Firm Regarding Their Rights

GoldMining Announces Renewed At-the-Market Equity Program

Eve’s Dryer Vent Cleaning of Bay Shore Elevates Home Safety Awareness with Exceptional Service and Customer Praise

Acute on Chronic Liver Failure Market Set to Grow by 2034 as Novel Therapeutic Approaches Enter Clinical Pipeline | DelveInsight